Jerusalem, 17 September, 2025 (TPS-IL) — Israeli biotech start-up Novella Innovative Technology, Ltd. has unveiled Novella Strawberry, a patent-pending, whole-cell strawberry ingredient designed for peak potency, bioavailability, and sustainability. Leveraging its proprietary AuraCell platform, Novella cultivates intact strawberry cells in a controlled environment, bypassing traditional agriculture and reducing resource use by 99%. The ingredient delivers antioxidant activity up to 100 times stronger than conventional extracts, while preserving the full spectrum of strawberry bioactives.
Novella Strawberry debuts at SupplySide West 2025 in Las Vegas.